Magnetic resonance imaging features of post-COVID-19 regional and invasive sino-nasal mucormycosis
Background Sino-nasal mucormycosis is an opportunistic, invasive fungal disease which has shown a rising trend in the setting of COVID-19. The objective of this study is to document and analyze demographic data, clinical presentation and MR imaging spectra for early detection and management of post-COVID-19 sino-nasal mucormycosis. Results Sixty-two cases of sino-nasal mucormycosis were enrolled in this study; their mean age was 50.65 ± 8.25 years, with significant female predominance. Nine patients (14.5%) had active COVID-19 and 53 (85.5%) were recent COVID-19 cases. Sixty patients have not received COVID-19 vaccine. The mean duration from the initial COVID-19 laboratory confirmation to the detection of sino-nasal mucormycosis was 25.7 +/− 4.6 days. Thirty-five patients (56.5%) were kept in the hospital for COVID management and 4 of them received intensive care unit (ICU) treatment. Twenty-seven patients (43.5%) were treated in home isolation. Corticosteroids were administered in 48 cases (77.4%). Twenty-nine patients (46.8%) had been given oxygen for an average time of 11.2 ± 4.15 days. Diabetes was found in 56 cases (90.3%). The most common clinical symptoms were headache, seen in 52 patients (83.87%). The ethmoid sinus was the most common paranasal sinus involved in our study, seen in 47 cases (75.81%). In 36 cases (58%), multiple sinuses were involved. MRI staging according to the extent of regional involvement. Stage 1 seen in 2 cases (3.23%), stage 2 in 13 cases (20.97%), stage 3 in 35 cases (56.45%) and stage 4 in 12 cases (19.35%). Conclusions MRI shows a spectrum of findings in sino-nasal mucormycosis. Imaging plays a major role in staging and assessing the extent of involvement and complications. In light of this, mortality and morbidity can be dramatically decreased with adequate evaluation and therapy..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
---|---|
Enthalten in: |
The Egyptian Journal of Radiology and Nuclear Medicine - 53(2022), 1 vom: 28. Nov. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Abd El Megid, Ahmed Gamil Ibrahim [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
---|
Anmerkungen: |
© The Author(s) 2022 |
---|
doi: |
10.1186/s43055-022-00930-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2132903255 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC2132903255 | ||
003 | DE-627 | ||
005 | 20240402141838.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230506s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s43055-022-00930-w |2 doi | |
035 | |a (DE-627)OLC2132903255 | ||
035 | |a (DE-He213)s43055-022-00930-w-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
100 | 1 | |a Abd El Megid, Ahmed Gamil Ibrahim |e verfasserin |0 (orcid)0000-0002-2788-8869 |4 aut | |
245 | 1 | 0 | |a Magnetic resonance imaging features of post-COVID-19 regional and invasive sino-nasal mucormycosis |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s) 2022 | ||
520 | |a Background Sino-nasal mucormycosis is an opportunistic, invasive fungal disease which has shown a rising trend in the setting of COVID-19. The objective of this study is to document and analyze demographic data, clinical presentation and MR imaging spectra for early detection and management of post-COVID-19 sino-nasal mucormycosis. Results Sixty-two cases of sino-nasal mucormycosis were enrolled in this study; their mean age was 50.65 ± 8.25 years, with significant female predominance. Nine patients (14.5%) had active COVID-19 and 53 (85.5%) were recent COVID-19 cases. Sixty patients have not received COVID-19 vaccine. The mean duration from the initial COVID-19 laboratory confirmation to the detection of sino-nasal mucormycosis was 25.7 +/− 4.6 days. Thirty-five patients (56.5%) were kept in the hospital for COVID management and 4 of them received intensive care unit (ICU) treatment. Twenty-seven patients (43.5%) were treated in home isolation. Corticosteroids were administered in 48 cases (77.4%). Twenty-nine patients (46.8%) had been given oxygen for an average time of 11.2 ± 4.15 days. Diabetes was found in 56 cases (90.3%). The most common clinical symptoms were headache, seen in 52 patients (83.87%). The ethmoid sinus was the most common paranasal sinus involved in our study, seen in 47 cases (75.81%). In 36 cases (58%), multiple sinuses were involved. MRI staging according to the extent of regional involvement. Stage 1 seen in 2 cases (3.23%), stage 2 in 13 cases (20.97%), stage 3 in 35 cases (56.45%) and stage 4 in 12 cases (19.35%). Conclusions MRI shows a spectrum of findings in sino-nasal mucormycosis. Imaging plays a major role in staging and assessing the extent of involvement and complications. In light of this, mortality and morbidity can be dramatically decreased with adequate evaluation and therapy. | ||
650 | 4 | |a MRI | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Mucormycosis | |
700 | 1 | |a AbdelHamid, Ghada Adel |4 aut | |
700 | 1 | |a Abd Elbary, Mohamed El-Sayed |4 aut | |
700 | 1 | |a Ghonimi, Nesma A. M. |4 aut | |
700 | 1 | |a Elagrody, Ahmed I. |4 aut | |
700 | 1 | |a Abd Elhamed, Marwa Elsayed |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Egyptian Journal of Radiology and Nuclear Medicine |d Springer Berlin Heidelberg, 2010 |g 53(2022), 1 vom: 28. Nov. |h Online-Ressource |w (DE-627)641391862 |w (DE-600)2583928-7 |w (DE-576)335273823 |x 2090-4762 |7 nnns |
773 | 1 | 8 | |g volume:53 |g year:2022 |g number:1 |g day:28 |g month:11 |
856 | 4 | 0 | |u https://dx.doi.org/10.1186/s43055-022-00930-w |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 53 |j 2022 |e 1 |b 28 |c 11 |